Sengenics
Christoph Waer is a partner at Summa Equity, focused on creating value in companies that have leading solutions to global challenges and have positive ESG outcomes for society. Mr. Waer has held investment roles of increasing seniority at Korys and was an advisor for the OMX Europe Venture Fund. He has been a board member for Agendia, reMYND NV, MIMETAS, MRM Technologies, MyCartis and Bluebee. Mr. Waer has earned several business and science degrees from KU Leuven.
This person is not in the org chart
This person is not in any offices
Sengenics
Sengenics is a functional proteomics company that leverages its patented KREX™ technology for production of full-length, correctly folded and functional proteins. KREX™ was invented and patented by Professor Jonathan Blackburn whilst he was a member of the faculty at the University of Cambridge.